Medison Pharma

Medison operates a unified commercialization platform, enabling biotech companies to globally plan, optimize, and launch advanced therapies. This platform provides an integrated suite of services covering regulatory, market access, medical affairs, sales, and distribution. This comprehensive approach accelerates the global reach of innovative treatments for complex conditions, streamlining market entry for partners.

The company was founded by Meir Jakobsohn, who serves as its Executive Chairman. Jakobsohn's insight was recognizing a critical gap in patient access to breakthrough therapies, especially for rare and severe diseases across international markets. He established Medison to create a partnership model allowing biotech firms to swiftly introduce products into underserved regions.

Medison primarily serves emerging biotech companies commercializing advanced therapies, ultimately benefiting patients with rare and severe diseases. Its mission is to ensure equitable and timely access to innovative medicines globally, delivering life-changing treatments to those in need. The company's vision is to continually expand this worldwide access.